The optimal model for molecular testing in patients with advanced ROS1+ NSCLC
Dr Tim Benepal describes his vision of the optimal testing model for molecular testing by answering two significant questions: Should all molecular testing be carried out in-house? And when in a patient’s diagnostic pathway should these tests be requested?
Dr Tim Benepal is a Consultant Medical Oncologist at St George’s Hospital NHS Trust in London. Dr Benepal completed his oncology training at the Royal Marsden and has been an oncologist for the last 20 years. Dr Benepal is also lead lecturer for St George’s undergraduate and postgraduate medical students. His research interests include lung cancer, mesothelioma and upper gastrointestinal disease.
NSCLC, Non-Small Cell Lung Cancer; NGS, Next Generation Sequencing
PP-XLK-GBR-1154 April 2020